Next, to determine the gene expression changes in treated blasts, we performed qPCR analyses of Growth Differentiation Factor 15 (GDF15), which is a biomarker for mitochondrial diseases or oxidative stress [51,52], as well as of a group of nuclear TFs responsible for blast survival and metabolic adaptation. Here, GDF15 is linked to inborn mitochondrial metabolism disorder.